Disorders of eating behavior and comorbid syndromes in obesity and methodsof their correction

Eating behavior and comorbid syndromes were investigated in 40 women with o besity. A frequent combination of obesity with disorders of eating behavior , with emotional-personality, psychoautonomic and algesic disorders as well as with appearance of affective disorders during dietetic nutrition (<<die tetic depression>>) required their correction. As a result of insufficiency of serotoninergic system of brain in pathogenesis of such disorders, fluox etine (prozac)-a selective inhibitor of serotonine reuptake - was used for treatment of eating disorders. Heterogeneity in the structure of the obesit y is shown. Disorders of eating behavior were combined with pronounced anxi ety, depression, algesic and psychoautonomic syndromes. Therapy with prozac during 3 months in dose of 20 mg daily resulted in decrease of weight. Nor malization of eating pattern, decrease of anxiety, depression, reaction to the external stimuli, increase of stress-resistance of patients, alteration s in eating liking, decrease of severity of disorders comorbid to obesity w ere observed. A conclusion is made that prozac is indicated for patients in whom pathology of eating behavior plays a significant role in pathogenesis of obesity.